Publications by authors named "M Andrejak"

Claim this Profile
S
Stroke under treatment with ustekinumab for psoriatic arthritis.
M Aboudiab, M Andréjak, T Husein, V Goëb

Rev Neurol (Paris)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From evidence-based medicine to personalized medicine, with particular emphasis on drug-safety monitoring.
Pierre-Vladimir Ennezat, Shona Cosgrove, Hélène Bouvaist, Sylvestre Maréchaux, Raphaëlle-Ashley Guerbaai

Arch Cardiovasc Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists.
Sophie Liabeuf, Kamel Masmoudi, Lucie-Marie Scailteux, Julien Moragny, Henri Masson, Michel Andrejak

Medicine (Baltimore)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-aortic obstruction of left ventricular outflow tract secondary to benfluorex-induced endocardial fibrosis.
Catherine Szymanski, Sylvestre Maréchaux, Patrick Bruneval, Michel Andréjak, Vincent Thomas de Montpréville

Int J Cardiol Heart Vasc· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists.
Sophie Liabeuf, Lucie-Marie Scaltieux, Kamel Masmoudi, Bertrand Roussel, Julien Moragny, Michel Andrejak

Medicine (Baltimore)· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis